Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 30, 2013CancerOpen Access

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

RJRichard W. JosephDaiichi Sankyo (United States)PKPayal KapurKidney Cancer AssociationDSDaniel SerieFederal Reserve Bank of San Francisco

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Joseph et al. (2013) studied this question.

synapsesocial.com/papers/6a1cc4e6f1b3da30e489a7dfhttps://doi.org/10.1002/cncr.28521
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <i>BAP1</i> and <i>SETD2</i> : A Report by MSKCC and the KIRC TCGA Research Network2013 · 358 citations
  2. 2MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS1996 · 10,015 citations
  3. 3Comprehensive molecular characterization of clear cell renal cell carcinoma2013 · 3,609 citations
  4. 4Cancer statistics, 20132013 · 11,921 citations